Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Anaesth Intensive Care ; 37(4): 608-12, 2009 Jul.
Article in English | MEDLINE | ID: mdl-19681420

ABSTRACT

Iatrogenic meningitis is a rare complication of spinal anaesthesia. It is mandatory to use a technique which minimises the risk of introducing bacteria into the subarachnoid space. Currently available fentanyl ampoules require a careful drawing-up technique, as the outside of the ampoule is not sterile and there is potential to contaminate the contents in the drawing-up process. We designed a pilot laboratory study to determine the extent of bacterial contamination of fentanyl solutions drawn up from non-sterile packaged glass fentanyl ampoules using three different methods: aspirating through a 5 microm filter needle only, aspirating through a 5 microm filter needle after swabbing the neck of the ampoule with isopropyl alcohol and aspirating through an antibacterial filter in addition to the 5 microm filter needle. Ten anaesthetists used each method once, in randomised order to draw up solution from three different fentanyl ampoules. Samples underwent bacterial culture in blood agar and enrichment broth for 48 hours. No significant growth was seen in any sample. This pilot study did not identify any bacterial contamination of fentanyl solution irrespective of which of the three methods for aspiration was used.


Subject(s)
Bacteria/isolation & purification , Drug Contamination , Drug Packaging , Equipment Contamination , Fentanyl , Meningitis, Bacterial/etiology
2.
J Intellect Disabil Res ; 49(Pt 5): 309-16, 2005 May.
Article in English | MEDLINE | ID: mdl-15817048

ABSTRACT

BACKGROUND: Coronary heart disease (CHD) is a major cause of morbidity and mortality in the UK. The aim of this study was to screen inpatients with mild or borderline intellectual disability, many of whom also have mental illness, for risk factors for CHD. METHODS: Cross sectional survey. Participants were interviewed, measured and had blood samples taken. RESULTS: Of the 53 participants, 20 (37.7%) were overweight and 18 (34.0%) obese. The mean body mass index (BMI) of those participants prescribed regular antipsychotics was higher than those who were not. Nine (20.9%) had waist circumference measurements placing them at increased risk of CHD and 21 (48.8%) were at substantially increased risk. Twenty-eight (52.8%) were current smokers. Of the 49 participants who had their blood pressure measured, 3 (6.1%) had readings above the reference range. Of the 19 participants who had random blood tests, one (5.3%) had an elevated cholesterol level. CONCLUSIONS: In this population there was a high prevalence of two risk factors for CHD (obesity and smoking), requiring ongoing monitoring and long-term measures to reduce risk.


Subject(s)
Coronary Disease/epidemiology , Intellectual Disability/epidemiology , Mental Disorders/epidemiology , Adolescent , Adult , Anthropometry , Blood Glucose , Body Mass Index , Cholesterol/blood , Coronary Disease/blood , Cross-Sectional Studies , Demography , Feedback , Female , Humans , Male , Mass Screening/methods , Risk Factors , Severity of Illness Index
3.
Drug Saf ; 10(6): 455-63, 1994 Jun.
Article in English | MEDLINE | ID: mdl-7917074

ABSTRACT

The therapeutic dosage of lithium is close to the toxic level, and drugs reducing the renal clearance of lithium can produce the most serious adverse effects. When used in combination with psychiatric drugs affecting mood, the therapeutic potential of lithium may be enhanced, and earlier concern regarding possible neurotoxic interactions with neuroleptics appear poorly substantiated. A number of specific interactions of low incidence have also been reported which should be borne in mind when new medications are introduced. The ready availability of lithium concentration monitoring in body fluids makes it possible to alter the effects of some potentially interactive drugs that may still need to be given in combination with lithium.


Subject(s)
Kidney/drug effects , Lithium/adverse effects , Psychotropic Drugs/pharmacology , Drug Interactions , Humans , Lithium/blood , Lithium/pharmacology , Lithium/therapeutic use , Psychotropic Drugs/pharmacokinetics
SELECTION OF CITATIONS
SEARCH DETAIL
...